{
  "ticker": "VRTX",
  "year": 2024,
  "quarter": 2,
  "last_updated": "2025-04-19T07:36:40.944791",
  "count": 14,
  "transactions": [
    {
      "id": 29419,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "SACHS BRUCE I",
      "reporting_owner_cik": "0001197036",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-22",
      "transaction_shares": "7073",
      "transaction_price": "93.51",
      "transaction_type": "M",
      "shares_after_transaction": "47073"
    },
    {
      "id": 29414,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-05-20",
      "transaction_shares": "15202",
      "transaction_price": "447",
      "transaction_type": "S",
      "shares_after_transaction": "121374"
    },
    {
      "id": 29397,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-05-15",
      "transaction_shares": "32",
      "transaction_price": "430.93",
      "transaction_type": "S",
      "shares_after_transaction": "55325"
    },
    {
      "id": 29407,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP,  Chief Scientific Officer",
      "transaction_date": "2024-05-15",
      "transaction_shares": "54",
      "transaction_price": "430.93",
      "transaction_type": "S",
      "shares_after_transaction": "25813"
    },
    {
      "id": 29409,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Schneider Jennifer",
      "reporting_owner_cik": "0001783060",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-15",
      "transaction_shares": "922",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "922"
    },
    {
      "id": 29441,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-05-15",
      "transaction_shares": "69",
      "transaction_price": "430.93",
      "transaction_type": "S",
      "shares_after_transaction": "49691"
    },
    {
      "id": 29435,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-05-14",
      "transaction_shares": "14112",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "30084"
    },
    {
      "id": 29388,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Thornberry Nancy",
      "reporting_owner_cik": "0001797826",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-01",
      "transaction_shares": "501",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "1637"
    },
    {
      "id": 29422,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "CARNEY LLOYD",
      "reporting_owner_cik": "0001204424",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-01",
      "transaction_shares": "1001",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6319"
    },
    {
      "id": 29423,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "MCKENZIE DIANA",
      "reporting_owner_cik": "0001754648",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-01",
      "transaction_shares": "1001",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3604"
    },
    {
      "id": 29430,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-01",
      "transaction_shares": "1001",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4902"
    },
    {
      "id": 29442,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Upadhyay Suketu",
      "reporting_owner_cik": "0001533149",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-01",
      "transaction_shares": "1001",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3727"
    },
    {
      "id": 16066,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "225",
      "transaction_price": "418.10",
      "transaction_type": "F",
      "shares_after_transaction": "7740"
    },
    {
      "id": 29395,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "225",
      "transaction_price": "418.10",
      "transaction_type": "F",
      "shares_after_transaction": "7740"
    }
  ]
}